Fresenius Medical…
USUSDFresenius Medical Care AG & Co. KGaA (LSE:0H9X) — Misc Health and Biotechnology Services. Número de bolsas en las que cotizan las acciones de la empresa: 5. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.
Sobre la Empresa
- Sitio Web
- fmcna.com
- Sector
- Health Care · Misc Health and Biotechnology Services
- Sede Central
- BAD HOMBURG, Germany
- Consejero Delegado
- Helen Giza
- Empleados
- 125 364
- Fundada
- 1975
- Cotiza Desde
- 31.03.2006 (LSE:0H9X)
- Acciones en Circulación
- 266.11 M a 2025-12-31
- Capital Flotante
- 198.56 M
- Capitalización Bursátil
- 11.86 mil M USD
- Insiders
- 25.02%
- Inversores Institucionales
- 52.82%
- Industria (SIC)
- Services-Misc Health & Allied Services, NEC
- Forma Jurídica
- 6QQB
- ISIN
- DE0005785802
- LEI
- 549300CP8NY40UP89Q40
- Ratio de Reparto
- 42.7%
- FCF
- 1.78 mil M EUR
- Pagos / FCF
- 22%
- Deuda
- 11.0 mil M EUR3.5 a. de FCF
- Racha de Dividendos
- 28 a.
- Beneficios, FCF y dividendos pagados — para los 12 meses hasta 30.06.2026 (el último informe de la compañía).
Descripción
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Bolsas y Tickers
| Bolsa | Ticker | Moneda | Precio | Tipo |
|---|---|---|---|---|
| US USA Stocks | FMCQF OTC | USD | 43.8204 +7.38% | acciones ordinarias |
| LSE London Stock Exchange | 0H9X IOB | EUR | 44.12 +0.00% | acciones ordinarias |
| MI Borsa Italiana (Milan) | 1FME secundaria | EUR | 39.1 -1.36% | acciones ordinarias |
| VI Vienna Stock Exchange | FME secundaria | EUR | 40.31 +0.12% | acciones ordinarias |
| XETRA Xetra | FME principal | EUR | 39.8 -1.68% | acciones ordinarias |
Dividendos
Fresenius Medical Care AG & Co. KGaA (FMCQF) paga dividendos una vez al año. Por año (12 meses hasta e incluyendo el último pago anunciado): 1.49 EUR por acción (pagos: 1). Según el historial de pagos, se espera la próxima fecha ex-dividendo alrededor de 24.05.2027. Historial de dividendos ininterrumpido: 28 años.
| Fecha Ex | Pago | Importe | % | Tipo | Ticker |
|---|---|---|---|---|---|
| 2026-05-22 | 2026-05-27 | 1.4900 EUR | 4.0/4.0 % | anual | US:FMCQF |
| 2025-05-23 | 2025-05-27 | 1.4400 EUR | 2.8/2.8 % | anual | US:FMCQF |
| 2024-05-17 | 2024-05-22 | 1.1900 EUR | 2.9/2.9 % | anual | US:FMCQF |
Noticias de Esta Semana
Comunicados de prensa desde la página web para inversores de la empresa, actualizados diariamente. Los enlaces conducen a la página web de la empresa. Los titulares están en el idioma original, como en la página web de la empresa.
Principales Accionistas
| Titular | Participación | Acciones | Fecha del Informe |
|---|---|---|---|
| Dodge & Cox Funds-Dodge… | 5.61% | 13.75 M | 2026-06-30 |
| Artisan Partners Funds I… | 2.68% | 6.58 M | 2026-06-30 |
| VANGUARD STAR FUNDS-Vang… | 1.25% | 3.07 M | 2026-07-31 |
| Dodge & Cox Funds-Dodge… | 1.06% | 2.61 M | 2026-06-30 |
| VANGUARD TAX-MANAGED FUN… | 0.8% | 1.95 M | 2026-06-30 |
| iShares Trust-iShares Co… | 0.59% | 1.44 M | 2026-08-31 |
| Columbia Funds Series Tr… | 0.57% | 1.4 M | 2026-05-31 |
| Bridge Builder Trust-Bri… | 0.55% | 1.35 M | 2026-06-30 |
| SEI INSTITUTIONAL INVEST… | 0.52% | 1.27 M | 2026-07-31 |
| Datum One Series Trust-B… | 0.44% | 1.08 M | 2026-06-30 |
| Pacer Advisors, Inc. | 0.16% | 387 540 | 2026-06-30 |
| Generali Investments Cee… | 0% | 9 100 | 2026-06-30 |
| Paradigm Asset Managemen… | 0% | 697 | 2026-06-30 |
